Search
Etiprednol dicloacetate
go.drugbank.com/drugs/DB05442InvestigationalAnti-asthmatic effects were associated with decreased cytokine production in lipopolysaccharide-stimulated lymphocytes and attenuated lectin-induced proliferation of blood mononuclear cells in tissue culture … Etiprednol dicloacetate (BNP-166) is a soft corticosteroid with anti-inflammatory properties that has been indicated in the treatment of asthma and Chron's disease.
Thioctic acid tromethamine
go.drugbank.com/drugs/DB06253ExperimentalA salt of alpha-lipoic acid and tromethamine; may be useful in treating vascular stress in patients with diabetes.
Talacotuzumab
go.drugbank.com/drugs/DB14796InvestigationalIt is under investigation in clinical trial NCT01632852 (A Study of CSL362 in Patients With CD123+ Acute Myeloid Leukemia Currently in Remission). … Talacotuzumab is an IgG1 monoclonal antibody directed toward the IL3 receptor α–subunit, also known as CD123.
GS-441524
go.drugbank.com/drugs/DB15686InvestigationalGS-441524 is an adenosine nucleotide analog antiviral, similar to [remdesivir].[A203057,L13239] This molecule was patented in 2009. … [L13775] _In vitro_ studies of GS-441524 have determined it has a higher EC<sub>50</sub> than remdesivir against a number of viruses, meaning GS-441524 is less potent.
Iopentol
go.drugbank.com/drugs/DB13861ExperimentalIopentol is used as a contrast medium.
Categories: Compounds used in a research, industrial, or household settingIobenzamic acid
go.drugbank.com/drugs/DB13428ExperimentalCategories: Compounds used in a research, industrial, or household settingIoglycamic acid
go.drugbank.com/drugs/DB13741ExperimentalCategories: Compounds used in a research, industrial, or household settingSimendan
go.drugbank.com/drugs/DB12286ExperimentalCategories: Compounds used in a research, industrial, or household settingSampatrilat
go.drugbank.com/drugs/DB21283ExperimentalSampatrilat is a small molecule drug. Sampatrilat has a monoisotopic molecular weight of 584.25 Da.
Categories: Agents Acting on the Renin-Angiotensin SystemINO-4800
go.drugbank.com/drugs/DB15693Investigational[A214475] A Phase 1 clinical trial for INO-4800 in the U.S. (NCT04336410) was started on April 3, 2020, with an expected completion date of July 2021. … [L14372] A Phase 1/2 clinical trial through South Korea's Seoul National University Hospital was announced on June 4, 2020, and expected to start later in the month.[L14375]
Categories: Complex Mixtures